Leading Healthcare Executive Rachel Hoover, MS, MBA, Named Executive Vice President at UM Faculty Physicians, Inc.

William F. Regine, MD, FACR, FASTRO, FACRO, President of University of Maryland Faculty Physicians, Inc. (FPI), along with University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD  announced today that Rachel L. Hoover, MS, MBA, will serve as the new FPI Executive Vice President and Chief Administrative Officer (EVP/CAO), effective May 1.

Ms. Hoover is a healthcare leader with more than 20 years of experience in providing strategic oversight and planning for enterprise-wide initiatives in academic and private health care systems. Most recently she served as Chief Operating Officer for Johns Hopkins Regional Physicians and was previously Director of Global Services for Johns Hopkins Medicine. 

“Rachel Hoover brings an extraordinarily deep and diverse portfolio of experience in financial and operational oversight of clinical care, education, and translational and clinical research,” said Dr. Regine, who is also the Senior Associate Dean for Clinical Affairs at UMSOM, the Isadore & Fannie Schneider Foxman Chair of Radiation Oncology, and Executive Director of the Maryland Proton Treatment Center. “She also has proven expertise in leading strategic planning, program management, and transformation initiatives, which makes her a perfect fit for implementing the new FPI integrated model that involves greater participation from departments.”

In this critical leadership position, Ms. Hoover will be responsible for establishing and executing the major objectives associated with FPI’s reinvigorated mission as an integrated multispecialty clinical enterprise of excellence, in alignment with University of Maryland Medical Center and Medica System (UMMC/UMMS) and community partners.

“I am honored to step into this important role and to work with such an esteemed group of experts,” said Ms. Hoover. “Having spent so many years on the other side of town, I have had the opportunity to admire the work this group does, and I look forward to partnering broadly with teams to achieve sustained growth and to support the expansive, strategic priorities of UMSOM and UMMC/UMMS.”

The redesign of FPI, implemented last year, involves an integrated group practice model in which departments have greater participation in the shared business plans and initiatives, and in financial growth, while preserving economies of scale and aspects of the previous “federated” model. Multiple advantages of the new structure include strengthening of FPI’s alignment with the University of Maryland Medical Center and Medical System, creating shared decision-making structures, and reducing artificial siloes and barriers.

“Given her experience and previous achievements, I am confident that Ms. Hoover will be successful in building efficiencies and process improvements within FPI,” said Mark T. Gladwin, MD, who is also Vice President for Medical Affairs, University of Maryland, Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor at UMSOM.  “She will also develop and implement operational plans to accelerate clinical growth and expand primary and multidisciplinary care in support of UMSOM and its UMMC/UMMS and community partners.”

University of Maryland Faculty Physicians, Inc. (FPI), is made up of more than 1,200 faculty members from the University of Maryland School of Medicine, providing care for more than 1.5 million outpatients and inpatients every year. UMSOM faculty physicians conduct cutting-edge research and clinical trials and offer care in more than 40 medical specialties. FPI treats patients nearby at more than 60 offices located across Maryland, as well as provides all clinical care at the University of Maryland Medical Center, one of the nation's leading academic medical centers, and some of the clinical care at all other UMMS hospitals.

“I look forward to working with Ms. Hoover in inspiring, motivating, and engaging our FPI team members, UM SOM faculty, and UMMC/UMMS and community partners to achieve goals that will benefit our patients and sustain and support current and new initiatives,” said Dr. Regine.  

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 46 academic departments, centers, institutes, and programs, and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.3 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic, and clinically based care for nearly 2 million patients each year. The School of Medicine has nearly $600 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The combined School of Medicine and Medical System (“University of Maryland Medicine”) has an annual budget of over $6 billion and an economic impact of nearly $20 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity (according to the Association of American Medical Colleges profile) is an innovator in translational medicine, with 606 active patents and 52 start-up companies. In the latest U.S. News & World Report ranking of the Best Medical Schools, published in 2021, the UM School of Medicine is ranked #9 among the 92 public medical schools in the U.S., and in the top 15 percent (#27) of all 192 public and private U.S. medical schools. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu